In vivo selection of antifolate-resistant transgenic hematopoietic stem cells in a murine bone marrow transplant model

Journal of Pharmacology and Experimental Therapeutics

Volumn 300, Issue 1, 2002, Pages 50-56

  Warlick, Christopher A ^a   Diers, Michaeleen D ^b   Wagner, John E ^c   Scott Mcivor, R ^a,d  

^a Institute of Human Genetics   (United States)

^b Department of Laboratory Medicine and Pathology ^*  (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; FOLIC ACID ANTAGONIST; NITROBENZYLTHIOINOSINE; TRIMETREXATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GENE THERAPY; GENE TRANSFER; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; STEM CELL; TRANSGENE;

ANIMALS; BLOTTING, SOUTHERN; BONE MARROW TRANSPLANTATION; FEMALE; FOLIC ACID ANTAGONISTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; LEUKOCYTE COUNT; MICE; MICE, TRANSGENIC; SPLEEN; TETRAHYDROFOLATE DEHYDROGENASE; THIOINOSINE; THIONUCLEOTIDES; TRIMETREXATE;

EID: 0036140101     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.300.1.50     Document Type: Article

References (24)

1. In vivo selection of retrovirally transduced hematopoietic stem cells
2. Sensitization of hematopoietic stem and progenitor cells to trimetrexate using nucleoside transport inhibitors
3. Cytokine prestimulation as a gene therapy strategy: Implications for using the MDR1 gene as a dominant selectable marker
4. Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells
5. Retrovirus-mediated gene transfer into human hematopoietic stem cells
6. Serial transplantation of methotrexate-resistant bone marrow: Protection of murine recipients from drug toxicity by progeny of transduced stem cells
7. 6-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection
8. 6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosurea
9. Increased transduction efficiency of primary hematopoietic cells by physical colocalization of retrovirus and target cells
10. Transgenic mice expressing the tyr22 variant of murine DHFR: Protection of transgenic marrow transplant recipients from lethal doses of methotrexate
11. Mild preconditioning and low level engraftment confer methotrexate resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity
12. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor
13. Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation: Implications for gene therapy
14. Protection of mice from lethal dose methotrexate by transplantation with transgenic marrow expressing drug-resistant dihydrofolate reductase activity
15. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
16. Saturation mutagenesis at dihydrofolate reductase codons 22 and 31. A variety of amino acid substitutions conferring methotrexate-resistance
17. Potentiation of methotrexate toxicity by dipyridamole
18. Adeno-associated virus type 2-mediated transduction of murine hematopoietic cells with long-term repopulating ability and sustained expression of a human globin gene in vivo
19. Isolation and expression of an altered mouse dihydrofolate reductase cDNA
20. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1
21. A gene transfer strategy for making bone marrow cells resistant to trimetrexate
22. Nucleoside transport inhibition maintains differential methotrexate toxicity between cells expressing drug-resistant and wild-type DHFR activities in the presence of nucleosides
23. Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow